281 related articles for article (PubMed ID: 15714079)
1. Late-onset Tay-Sachs disease: phenotypic characterization and genotypic correlations in 21 affected patients.
Neudorfer O; Pastores GM; Zeng BJ; Gianutsos J; Zaroff CM; Kolodny EH
Genet Med; 2005 Feb; 7(2):119-23. PubMed ID: 15714079
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and molecular characterization of non-classic forms of Tay-Sachs disease in Brazil.
Rozenberg R; Kok F; Burin MG; Sá Miranda MC; Vasques C; Henriques-Souza AM; Giugliani R; Vainzof M; Pereira LV
J Child Neurol; 2006 Jun; 21(6):540-4. PubMed ID: 16948947
[TBL] [Abstract][Full Text] [Related]
3. The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.
Maegawa GH; Stockley T; Tropak M; Banwell B; Blaser S; Kok F; Giugliani R; Mahuran D; Clarke JT
Pediatrics; 2006 Nov; 118(5):e1550-62. PubMed ID: 17015493
[TBL] [Abstract][Full Text] [Related]
4. Amyotrophy, cerebellar impairment and psychiatric disease are the main symptoms in a cohort of 14 Czech patients with the late-onset form of Tay-Sachs disease.
Jahnová H; Poupětová H; Jirečková J; Vlášková H; Košťálová E; Mazanec R; Zumrová A; Mečíř P; Mušová Z; Magner M
J Neurol; 2019 Aug; 266(8):1953-1959. PubMed ID: 31076878
[TBL] [Abstract][Full Text] [Related]
5. Late-onset Tay-Sachs disease presenting with a neuromuscular phenotype-a case series.
Fullam S; Togher Z; Power A; Kennelly L; McHugh JC; O'Dowd S; Tubridy N; Hardiman O; Costigan D; Ryan A; Lefter S; Connolly S; Murphy SM
Eur J Neurol; 2024 Jan; 31(1):e16069. PubMed ID: 37754769
[TBL] [Abstract][Full Text] [Related]
6. Comparison of enzyme and DNA analysis in a Tay-Sachs disease carrier screening program.
Yoo HW; Astrin KH; Desnick RJ
J Korean Med Sci; 1993 Feb; 8(1):84-91. PubMed ID: 8343225
[TBL] [Abstract][Full Text] [Related]
7. Progressive cerebellar ataxia, proximal neurogenic weakness and ocular motor disturbances: hexosaminidase A deficiency with late clinical onset in four siblings.
Hund E; Grau A; Fogel W; Forsting M; Cantz M; Kustermann-Kuhn B; Harzer K; Navon R; Goebel HH; Meinck HM
J Neurol Sci; 1997 Jan; 145(1):25-31. PubMed ID: 9073025
[TBL] [Abstract][Full Text] [Related]
8. The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease.
Navon R; Proia RL
Science; 1989 Mar; 243(4897):1471-4. PubMed ID: 2522679
[TBL] [Abstract][Full Text] [Related]
9. [Tay-Sachs disease].
Tanaka A
Nihon Rinsho; 1993 Sep; 51(9):2281-5. PubMed ID: 8411703
[TBL] [Abstract][Full Text] [Related]
10. Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene.
Myerowitz R
Hum Mutat; 1997; 9(3):195-208. PubMed ID: 9090523
[TBL] [Abstract][Full Text] [Related]
11. Patient and caregiver perspectives on burden of disease manifestations in late-onset Tay-Sachs and Sandhoff diseases.
Lyn N; Pulikottil-Jacob R; Rochmann C; Krupnick R; Gwaltney C; Stephens N; Kissell J; Cox GF; Fischer T; Hamed A
Orphanet J Rare Dis; 2020 Apr; 15(1):92. PubMed ID: 32295606
[TBL] [Abstract][Full Text] [Related]
12. Prenatal Diagnosis of Tay-Sachs Disease.
Zhang J; Chen H; Kornreich R; Yu C
Methods Mol Biol; 2019; 1885():233-250. PubMed ID: 30506202
[TBL] [Abstract][Full Text] [Related]
13. Late-onset GM2 gangliosidosis: Ashkenazi Jewish family with an exon 5 mutation (Tyr180-->His) in the Hex A alpha-chain gene.
De Gasperi R; Gama Sosa MA; Battistini S; Yeretsian J; Raghavan S; Zelnik N; Leshinsky E; Kolodny EH
Neurology; 1996 Aug; 47(2):547-52. PubMed ID: 8757036
[TBL] [Abstract][Full Text] [Related]
14. An inducible mouse model of late onset Tay-Sachs disease.
Jeyakumar M; Smith D; Eliott-Smith E; Cortina-Borja M; Reinkensmeier G; Butters TD; Lemm T; Sandhoff K; Perry VH; Dwek RA; Platt FM
Neurobiol Dis; 2002 Aug; 10(3):201-10. PubMed ID: 12270683
[TBL] [Abstract][Full Text] [Related]
15. Pontocerebellar atrophy is the hallmark neuroradiological finding in late-onset Tay-Sachs disease.
Májovská J; Hennig A; Nestrasil I; Schneider SA; Jahnová H; Vaněčková M; Magner M; Dušek P
Neurol Sci; 2022 May; 43(5):3273-3281. PubMed ID: 34800199
[TBL] [Abstract][Full Text] [Related]
16. Alpha-locus hexosaminidase genetic compound with juvenile gangliosidosis phenotype: clinical, genetic, and biochemical studies.
Johnson WG; Cohen CS; Miranda AF; Waran SP; Chutorian AM
Am J Hum Genet; 1980 Jul; 32(4):508-18. PubMed ID: 6772023
[TBL] [Abstract][Full Text] [Related]
17. 31Phosphorus magnetic resonance spectroscopy in late-onset Tay-Sachs disease.
Felderhoff-Mueser U; Sperner J; Konstanzcak P; Navon R; Weschke B
J Child Neurol; 2001 May; 16(5):377-80. PubMed ID: 11392526
[TBL] [Abstract][Full Text] [Related]
18. Two new mutations in a late infantile Tay-Sachs patient are both in exon 1 of the beta-hexosaminidase alpha subunit gene.
Harmon DL; Gardner-Medwin D; Stirling JL
J Med Genet; 1993 Feb; 30(2):123-8. PubMed ID: 8445615
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Tips from a Video Series and Literature Review of Patients with Late-Onset Tay-Sachs Disease.
Riboldi GM; Lau H
Tremor Other Hyperkinet Mov (N Y); 2022; 12():34. PubMed ID: 36618998
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]